EU/3/07/478: Public summary of positive opinion for orphan designation of N-(2-amino-phenyl)-4-[(4-pyridin-3-yl-pyrimidin-2-ylamino)-methyl] benzamide for the treatment of Hodgkin's lymphoma
(PDF/317.04 KB)
(updated)
Adopted
First published: 23/09/2009
Last updated: 10/05/2022
EMEA/COMP/389996/2007 Rev.1